Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in decreased expression of JARID2 mRNA | decreases expression | 20713471
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in decreased expression of JARID2 mRNA | decreases expression | 20406850
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of JARID2 mRNA | decreases expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of JARID2 mRNA | decreases expression | 20382639
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of JARID2 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of JARID2 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of JARID2 mRNA | affects cotreatment|increases expression | 17942748
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of JARID2 mRNA | affects cotreatment|increases expression | 17183730
|
C013038 |
hydroxyhydroquinone |
hydroxyhydroquinone results in increased expression of JARID2 mRNA | increases expression | 17572062
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of JARID2 mRNA | decreases expression | 12057914
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of JARID2 mRNA | affects binding|increases activity|increases expression | 19710929
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of JARID2 mRNA | affects cotreatment|increases expression | 17942748
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of JARID2 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.97 | 15322242 11752688 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.97 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.07 | 19490988 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.16 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
9.55 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
9.55 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.28 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.28 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.73 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.56 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.56 | 16835633 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.45 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.08 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.68 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.25 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.64 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.74 | 15885639 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 19232924 18985861 18940202 17507914 19460635 18558336 17157402 18316065 18396377 15238991 17688650 20603192 18775368 18177632 16609825 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.14 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.24 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.24 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.01 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.31 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.31 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
1.92 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.92 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.92 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.91 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
1.77 | 16705839 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.08 | 20419170 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.44 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.96 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.96 | 20889678 |
MESH:D002659 |
Child Development Disorders, Pervasive |
marker/mechanism |
|
| 21308764 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.75 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
8.09 | 17333356 17681005 15861022 16919318 11677210 16105132 17110522 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.09 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.15 | 12621046 15340226 16354765 8697196 15668235 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.18 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.51 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.51 | 8888407 16575769 17688650 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.19 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.48 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.41 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.41 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.41 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.86 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.20 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.00 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.00 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.12 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.35 | 12538720 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.15 | 10568697 9294722 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.59 | 15328337 17637181 15821434 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.33 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.13 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.00 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.71 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.47 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.26 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.46 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.46 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.12 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.89 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.89 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
13.89 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.63 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.10 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.29 | 8888407 18558336 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
4.14 | 9205823 11852909 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.12 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.81 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.67 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.67 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.62 | 20558911 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.52 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.48 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.85 | 16221962 18467677 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.85 | 15340226 12621046 16120746 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.06 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.26 | 8697196 18606429 15340226 16959395 16354765 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.31 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.95 | 18670907 18850075 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.80 | 16612254 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.98 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.61 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.57 | 17937319 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
5.30 | 12878042 17255318 17237260 9205823 17963957 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.30 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.72 | 16306350 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.78 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.48 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.09 | 16705839 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.17 | 17596541 16294345 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.89 | 15821434 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
3.53 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.53 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.53 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
11.06 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
11.06 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
11.06 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.06 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.01 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.01 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.48 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
4.18 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.22 | 17053015 18569708 18816296 20135361 20464547 20869020 18520028 6695378 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.22 | 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
3.66 | 11921183 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.29 | 18803445 18765137 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.30 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.68 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.17 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.23 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.19 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.13 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.05 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.05 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.03 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.03 | 17405874 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.37 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.21 | 16359493 8888407 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.56 | 16049721 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.84 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.47 | 12520081 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.75 | 11605937 12224865 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.72 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.12 | 11399792 11896295 11222880 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
10.12 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.95 | 17292933 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.51 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.76 | 11422049 12752131 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.45 | 19058328 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.82 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.00 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.32 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.08 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.25 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
6.25 | 14763951 17978042 3137016 15475178 1511512 11738929 11044598 16876388 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.67 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.67 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.16 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.89 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.76 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.30 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.77 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.28 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.12 | 12697716 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.45 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.71 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.14 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.14 | 17053015 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.82 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.51 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.46 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.81 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.68 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.47 | 15886252 |